INTRODUCTION
The Ramsay Hunt Syndrome (RHS), also called by Herpes Zoster Oticus (HZO), is a disease caused by reactivation of varicella zoster virus (VZV) in the geniculate ganglia. This illness represents the second cause of peripheral facial paralysis (PFP) atraumatic and occurs in 7-16% of cases. (1, 2) Although it could manifest in any age, the incidence of RHS is higher in the second and third decades of life, and it is uncommon in childhood. It is also higher in immunosuppressed patients, like HIV positives, in use of cytotoxic and steroid medications. (1) The presence of PFP and ipsilateral otalgia accompanied by vesicles in the auditory canal are classic syndrome of HZO. (1) (2) (3) Vertigo, nausea, vomiting, nystagmus and sensorineural hearing loss are additional clinical features. (1, 2) Involvement of cranial nerves trigeminal, glosopharyngeal, vagus and hypoglossal occurs less frequently. (1) The diagnosis is basically clinic and, in doubtful cases, by laboratorial confirmation. The recommended treatment for RHS is corticosteroid and antiviral therapy. (2) (3) (4) Studies demonstrate that the combined therapy reveals a better prognostic of the patient. (4) The presented case demonstrates the classic triad of the disease, but it is essential that the clinician look carefully to the several presentations, since RHS can present only vague symptoms or atypical scenario.
CASE REPORT
A 57 years old man with previous healthy condition of osteomyelitis, gout and hypertension presented with edema in the right external auditory pavilion and otalgia. He presented with edema in the right external auditory pavilion and earache. On his first consultation by general practitioner it was prescribed Amoxicilin after suggestion of a bacterial infection process, but without symptoms improvement. In the third day of evolution, the patient presented ipsilateral peripheral facial paralysis accompanied by vesicles in the right external auditory canal, 
DISCUSSION
The RHS is a rare presentation of Herpes Zoster characterized by peripheral facial paralysis, erythematous vesicles in auditory pavilion and cochlear and vestibular symptoms. (2) The incidence is 5/100.00 habitants/year and it increase by age: about 3/100/year in 20-50 years old people and 10/1000/year in age of 80. (5) It shows a worst prognostic than Bell palsy, having total recover in 30% of cases. (3, 6) The HZO appears by reactivation of varicella zoster virus, resulting from immunosuppression factors -like stress, fever, radiotherapy, tissue damage -in geniculate ganglia. (2, (6) (7) (8) The VZV, during RHS evolution, replicates in dorsal spinal nerve roots and cause intense inflammatory activity and tumor necrosis responsible for disease symptoms. (2, 6) As differential diagnosis we have Bell palsy, Lyme disease, trauma, metabolic diseases and tumors. (3) The PFP can precede vesicular eruptions. (2) In prospective study, 14% of diagnosed patients with RHS presented vesicular eruptions after facial involvement. (1) Although the classic triad of HZO is PFP and ipsilateral earache accompanied by vesicular lesions in auditory pavilion, some experts do not considerate the presence of vesicles necessary to diagnosis of this pathology -RHS sine herpete. (3) Several clinical presentations are possible in this scenario, having an essential characteristic the unilateral involvement of facial nerve. (1) The literature brings as most prominent symptoms the presence of PFP, earache, erythematous lesions in auditory pavilion, nausea, vertigo, sensorineural hearing loss. (1, 2, 6, 9, 10) Buzz and nistagmus may also be present in HZO. (11) Other related symptoms are due to lesion of other cranial nerves like trigeminal, glosopharyngeal, vagus and hypoglossal. (1, 6, 9, 11) Although the RHS diagnosis is predominantly clinical, virological and serological tests to identification of VZV are indicated in atypical cases, like HZO sine herpet. (1, 9, 10) It is important to establish the topographic diagnosis of facial nerve lesion through tearing evaluation by Schirmer test, stapes reflex by impedance audiometry and, finally, gustometry of anterior portion of the tongue. (3) The early diagnosis is essential, since the early institution of therapy minimize the risk of disease's sequelae. (9) Retrospectives studies and case reports demonstrate that the better therapy option to RHS is the association between antiviral and corticosteroids agents. (1, 6) In a study, the institution of combined therapy in the first 72 hours of the symptoms resulted in better prognostic and sequelae rate of patients, having a percentage of total healing in 75% of cases. (1, 3) An antiviral medication that is most widely used is Acyclovir 800mg/dia, orally, 5 times per day for 7 days. (3) Immunosuppression patients, children or in case of serious disease complications, it is recommended a therapy with Acyclovir, endovenously, at a dose of 10mg/kg/day, every 8 hours, for a period of 7 to 10 days. (7) Other therapy options are Valacyclovir, that present efficiency slightly higher than Acyclovir and Fancyclovir. (11) This medication reduces the acute symptoms duration of HZO and prevents nerve damages in long term. (3) The corticotherapy is indicated in cases of polyneuritis, moderate to severe pain, since corticosteroid decreases the pain degree associated with HZO and nerve inflammation and can be helpful in the management of the facial paralysis of RHS. (3, 6) However, many authors caution against implementing steroid therapy, especially with periocular lesions, as they fear dissemination of the VZV infection. (6) Other option is surgical decompression of facial nerve in case of persistent neuralgia and severe PFP. (2, 4) It is noteworthy that despite the institution of appropriate therapeutic, patients with sequelae correspond to 24 to 90% of cases, being possible complications the post herpetic neuralgia, syncinesis, ophthalmopathies, segmental myelitis and encephalitis. (2) The most common and important sequelae of this syndrome is facial palsy, that can attain maximum
